en
ua
en
EGW-NewsGamingAll newsMeet the New Faces of Genshin Impact 4.7: Clorinde, Sigewinne, and Sethos Join the Adventure!
Featured
Meet the New Faces of Genshin Impact 4.7: Clorinde, Sigewinne, and Sethos Join the Adventure!
1273
0
0

Meet the New Faces of Genshin Impact 4.7: Clorinde, Sigewinne, and Sethos Join the Adventure!

Genshin Impact Version 4.7 is set to introduce three new characters—Clorinde, Sigewinne, and Sethos—as the game transitions out of the Fontaine era. This update is expected to continue enriching the game’s mechanics, following the innovative gameplay elements introduced in previous patches.

During the earlier phases of Fontaine, characters like Lyney, Neuvillette, and Wriothesley showcased the Hit Point fluctuation mechanic, with Neuvillette emerging as a standout on-field character. This gameplay dynamic was further developed in Version 4.2 with the introduction of Furina, whose abilities enhanced the interaction of this mechanic with established characters such as Eula and Hu Tao.

Farmskins

Sign up now and get 2 FREE CASES + 5$ Bonus

Farmskins
CS:GO
Claim bonus
CSGOLuck

3 Free Cases + 100% up to 100 Coins on First Deposit

CSGOLuck
CS:GO
Claim bonus
Chicken.gg

Free gems, plus daily, weekly, & monthly boosts!

Chicken.gg
CS:GO
Claim bonus

Version 4.6 will debut Arlecchino, who will usher in the Bond of Life mechanic that will be further explored with Clorinde and Sigewinne in Version 4.7. Clorinde is expected to serve as an on-field character similar to Arlecchino, while Sigewinne is anticipated to function as a healer with significant on-field capabilities, akin to Kokomi. Additionally, Sethos, a Sumeru character and a 4-Star Electro Bow wielder, will make his first appearance in Version 4.6 during Cyno’s second Story Quest and will continue into the next version.

The upcoming update will also advance the Dainsleif storyline, likely connecting it to the newly introduced underwater ruins of Remuria introduced in Version 4.6. This suggests a deeper exploration of the game's lore and environment.

Although some players were disappointed that Sigewinne wasn’t announced as a 4-Star character—given the scarcity of 4-Star Hydro options—the potential for her to enable the Bond of Life mechanic could significantly enhance the utility of Clorinde and Arlecchino, especially in teams that rely on characters like Zhongli for shield support.

Further details about Clorinde, Sigewinne, and Sethos are expected as beta testing for Version 4.7 commences on April 24, 2024, promising new strategies and deeper gameplay interactions for Genshin Impact players.

Leave comment
Did you like the article?
0
0

Comments

Skin betting platforms
Farmskins

Sign up now and get 2 FREE CASES + 5$ Bonus

CSGOLuck

3 Free Cases + 100% up to 100 Coins on First Deposit

Chicken.gg

Free gems, plus daily, weekly, & monthly boosts!

Booster

15% Deposit bonus + Free case!

Bloody Case

5 Free Cases, Daily FREE & Welcome Bonuses up to 35%

SkinFans

Sign up and get a FREE Gift Case, Bonus Cases, Daily Coins, and Rakeback Rain!

Plunder

5 FREE Cases & 5% Deposit Bonus with code: EGAMERSW

CSFAIL

EXTRA 10% DEPOSIT BONUS + FREE 2 WHEEL SPINS
Promocode - EGAMERS10

GGDrop

EGAMERSW - get 11% Deposit Bonus + Bonus Wheel free spin

Cases.gg

Free daily case + 5% deposit bonus

OPCASES

Get 5% bonus and 5 FREE Cases Using Code: EGAMERSW

Clash GG

5% deposit bonus up to 100 gems

Daddy Skins

Code "EGW" for 8% bonus. Daily Free Cases. Hourly in-site giveaways

CSGO empire

a free Gift Case

CSGOPolygon

Up to 4% Rakeback Bonus

CSGORoll

3 free cases and a 5% bonus added to all cash deposits.

Dat Drop

Get 5% bonus on your deposit

Keydrop

10% TOP UP BONUS + $0.50

CSGOBIG

Grants you 5% deposit with promocode: egw

Insane GG

+100% bonus on first deposit.

G4 Skins

+5% to deposit

CaseDrop

2% Deposit Bonus

HellTV Store

Free Case and Deposit Bonus

BRING TO TOP
FREE SUBSCRIPTION ON EXCLUSIVE CONTENT
Receive a selection of the most important and up-to-date news in the industry.
*
*Only important news, no spam.
SUBSCRIBE
LATER
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic.
Customize
OK